AbbVie to seek FDA approval for leukemia drug after trial success

ReutersAbbVie to seek FDA approval for leukemia drug after trial successReutersAbbVie Inc on Wednesday said its experimental treatment for a form of leukemia associated with a gene mutation met its primary goal in a mid-stage trial and that the company would seek U.S. approval of the medicine, which analysts have said has ...Phase 2 Study of Venetoclax in Patients with Relapsed/Refractory Chronic ...CNNMoneyPivotal Phase II Study of Investigational Medicine Venetoclax Met Primary ...Business Wire (press release)AbbVie's venetoclax Phase 2 trial meets primary endpoint in patients with ...News-Medical.netall 5 news articles »